Medical Advisory Board
Adam M. Brufsky, MD, PhD
Dr. Brufsky is Professor of Medicine at the University of Pittsburgh School of Medicine. He serves as Co-Director, Comprehensive Breast Cancer Center and Medical Director, Women’s Cancer Center at the UPMC Magee Women’s Hospital, Pittsburgh, PA. Dr. Brufsky received an AB in Chemistry (Cum Laude) from Dartmouth College in Hanover, New Hampshire. He earned his MD and his PhD in Developmental Biology at the University of Connecticut School of Medicine in Farmington, CT. | Show More
He was an Intern and Resident in Internal Medicine at Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. He then completed a Fellowship in Medical Oncology and Bone Marrow Transplantation and the Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, where his appointments included Associate Physician and Instructor in Medicine at Dana Farber Cancer Institute and Harvard Medical School in Boston, MA. Dr. Brufsky is board certified in Internal Medicine and Medical Oncology by the American Board of Internal Medicine. He is an active member of the American Society of Clinical Oncology and the American Association for Cancer Research. He has authored or co-authored more than 300 abstracts and research articles in leading journals, including the New England Journal of Medicine, Journal of Clinical Investigation, Journal of Clinical Oncology, and Lancet Oncology. Dr. Brufsky is a Principal Investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army Breast Cancer Research Program. | show less
Massimo Cristofanilli, MD, FACP
Dr. Cristofanilli currently serves as Chief, Breast Medical Oncology; Associate Director, Precision Medicine Oncology at the Sandra and Edward Meyer Cancer Center; Scientific Director, the Englander, Institute of Precision Medicine. He obtained his medical degree from the University “La Sapienza” in Rome with Honors where he completed his fellowship in medical oncology. Subsequently, he completed a medical oncology fellowship at The University of Texas MD Anderson Cancer Center, where he also served as Faculty in the Department of Breast Medical Oncology for over a decade. | Show More
Dr. Cristofanilli’s extensive academic experience includes roles as Chairman of Medical Oncology and Associate Director of Clinical Research at the Fox Chase Cancer Center, Associate Director of Translational Research at Thomas Jefferson University, Professor of Medicine at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago and Director of Robert Lurie Cancer Center OncoSET Precision Medicine Program His research on biomarkers of endocrine resistance in breast cancer, liquid biopsies, novel drug development, circulating tumor cells (CTCs) and ctDNA have led to improved care for breast cancer patients. He is recognized for his contribution to the field of drug development in metastatic and locally advanced breast cancer and Inflammatory Breast Cancer (IBC), the detection and monitoring of micro metastatic disease in breast cancer. Moreover, he is Founder and President of the IBC International Consortium and has co-authored more than 400 peer-reviewed manuscripts. | show less